A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
ALA-induced fluorescence- lung cancer
Determine the relationship between ALA induced protoporphyrin IX (PplX) flourescence and histology in both normal and malignant tumors.
Participants will be followed for duration of the hospital stay, and up to 3 weeks after
No
Cherie P Erkmen, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
United States: Food and Drug Administration
D1046
NCT01611584
July 2013
December 2013
Name | Location |
---|---|
Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire 03756 |